Related Experiment Video
Updated: Jun 10, 2026
05:52
Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
Published on: May 12, 2023
[Persistent neutropenia].
S Bürki1, Andreas Oestmann, D Vogel
1Universitätsklinik für Allgemeine Innere Medizin, Inselspital, Universitätsspital Bern, Bern.
Praxis
|August 12, 2010
Summary
A 72-year-old patient with persistent neutropenia was diagnosed with immune neutropenia and systemic lupus erythematosus. Treatment with steroids effectively managed the symptoms, indicating a successful therapeutic approach.
Area of Science:
- Internal Medicine
- Hematology
- Rheumatology
Background:
- Persistent neutropenia can be a challenging diagnostic puzzle, often requiring thorough investigation.
- Sialadenitis, inflammation of salivary glands, can sometimes be an incidental finding during the workup of other conditions.
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
Observation:
- A 72-year-old patient presented with persistent neutropenia, initially investigated in the context of sialadenitis.
- Further diagnostic evaluation revealed the co-existence of immune neutropenia and systemic lupus erythematosus.
- The clinical presentation and history made drug-induced lupus erythematosus an unlikely cause.
Findings:
- The patient was diagnosed with immune neutropenia and systemic lupus erythematosus.
- A trial of steroid therapy was initiated.
- Steroid maintenance therapy resulted in good symptomatic control.
Implications:
- This case highlights the importance of considering autoimmune disorders in patients with unexplained neutropenia.
- Early diagnosis and appropriate management, such as with corticosteroids, can lead to favorable outcomes in patients with immune neutropenia and SLE.
- Understanding the interplay between different autoimmune conditions is crucial for comprehensive patient care.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...